Temporary G codes are assigned to services and procedures that are under review before being included in the CPT coding system. Payment for these services is under the jurisdiction of the local carriers.

View All HCPCS Sections

• G9636

  Health-related quality of life not assessed with tool during at least two visits or quality of life score declined

• G9637

  Final reports with documentation of one or more dose reduction techniques (e.g., automated exposure control, adjustment of the ma and/or kv according to patient size, use of iterative reconstruction technique)

• G9638

  Final reports without documentation of one or more dose reduction techniques (e.g., automated exposure control, adjustment of the ma and/or kv according to patient size, use of iterative reconstruction technique)

• G9639

  Major amputation or open surgical bypass not required within 48 hours of the index endovascular lower extremity revascularization procedure

• G9640

  Documentation of planned hybrid or staged procedure

• G9641

  Major amputation or open surgical bypass required within 48 hours of the index endovascular lower extremity revascularization procedure

• G9642

  Current smoker (e.g., cigarette, cigar, pipe, e-cigarette or marijuana)

• G9643

  Elective surgery

• G9644

  Patients who abstained from smoking prior to anesthesia on the day of surgery or procedure

• G9645

  Patients who did not abstain from smoking prior to anesthesia on the day of surgery or procedure

• G9646

  Patients with 90 day mrs score of 0 to 2

• G9647

  Patients in whom mrs score could not be obtained at 90 day follow-up

• G9648

  Patients with 90 day mrs score greater than 2

• G9649

  Psoriasis assessment tool documented meeting any one of the specified benchmarks (e.g., (pga; 5-point or 6-point scale), body surface area (bsa), psoriasis area and severity index (pasi) and/or dermatology life quality index) (dlqi))

• G9650

  Documentation that the patient declined therapy change or has documented contraindications (e.g., experienced adverse effects or lack of efficacy with all other therapy options) in order to achieve better disease control as measured by pga, bsa, pasi, or dlqi

• G9651

  Psoriasis assessment tool documented not meeting any one of the specified benchmarks (e.g., (pga; 5-point or 6-point scale), body surface area (bsa), psoriasis area and severity index (pasi) and/or dermatology life quality index) (dlqi)) or psoriasis assessment tool not documented

• G9652

  Patient has been treated with a systemic or biologic medication for psoriasis for at least six months

• G9653

  Patient has not been treated with a systemic or biologic medication for psoriasis for at least six months

• G9654

  Monitored anesthesia care (mac)

• G9655

  A transfer of care protocol or handoff tool/checklist that includes the required key handoff elements is used

• G9656

  Patient transferred directly from anesthetizing location to pacu or other non-icu location

• G9657

  Transfer of care during an anesthetic or to the intensive care unit

• G9658

  A transfer of care protocol or handoff tool/checklist that includes the required key handoff elements is not used

• G9659

  Patients greater than or equal to 86 years of age who underwent a screening colonoscopy and did not have a history of colorectal cancer or other valid medical reason for the colonoscopy, including: iron deficiency anemia, lower gastrointestinal bleeding, familial adenomatous polyposis, lynch syndrome (i.e., hereditary non-polyposis colorectal cancer), inflammatory bowel disease (i.e., crohn's disease or ulcerative colitis), abnormal finding of gastrointestinal tract, weight loss, or changes in bowel habits

• G9660

  Documentation of medical reason(s) for a colonoscopy performed on a patient greater than or equal to 86 years of age (e.g., iron deficiency anemia, lower gastrointestinal bleeding, familial history of adenomatous polyposis, lynch syndrome (i.e., hereditary non-polyposis colorectal cancer), inflammatory bowel disease (i.e., crohn's disease or ulcerative colitis), abnormal finding of gastrointestinal tract, weight loss, or changes in bowel habits)

• G9661

  Patients greater than or equal to 86 years of age who received a colonoscopy for an assessment of signs/symptoms of gi tract illness, and/or because the patient meets high risk criteria, and/or to follow-up on previously diagnosed advanced lesions

• G9662

  Previously diagnosed or have a diagnosis of clinical ascvd, including ascvd procedure

• G9663

  Any ldl-c laboratory result >= 190 mg/dl

• G9664

  Patients who are currently statin therapy users or received an order (prescription) for statin therapy

• G9665

  Patients who are not currently statin therapy users or did not receive an order (prescription) for statin therapy

• G9666

  Patient's highest fasting or direct ldl-c laboratory test result in the measurement period or two years prior to the beginning of the measurement period is 70-189 mg/dl

• G9667

  Documentation of medical reason(s) for not currently being a statin therapy user or receive an order (prescription) for statin therapy (e.g., patient with adverse effect, allergy or intolerance to statin medication therapy, patients who have an active diagnosis of pregnancy or who are breastfeeding, patients who are receiving palliative care, patients with active liver disease or hepatic disease or insufficiency, patients with end stage renal disease (esrd), and patients with diabetes who have a fasting or direct ldl-c laboratory test result < 70 mg/dl and are not taking statin therapy)

• G9669

  I intend to report the multiple chronic conditions measures group

• G9670

  All quality actions for the applicable measures in the multiple chronic conditions measures group have been performed for this patient

• G9671

  I intend to report the diabetic retinopathy measures group

• G9672

  All quality actions for the applicable measures in the diabetic retinopathy measures group have been performed for this patient

• G9673

  I intend to report the cardiovascular prevention measures group

• G9674

  Patients with clinical ascvd diagnosis

• G9675

  Patients who have ever had a fasting or direct laboratory result of ldl-c = 190 mg/dl

• G9676

  Patients aged 40 to 75 years at the beginning of the measurement period with type 1 or type 2 diabetes and with an ldl-c result of 70-189 mg/dl recorded as the highest fasting or direct laboratory test result in the measurement year or during the two years prior to the beginning of the measurement period

• G9677

  All quality actions for the applicable measures in the cardiovascular prevention measures group have been performed for this patient

• G9678

  Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation agreement

• G9679

  This code is for onsite acute care treatment of a nursing facility resident with pneumonia; may only be billed once per day per beneficiary

• G9680

  This code is for onsite acute care treatment of a nursing facility resident with chf; may only be billed once per day per beneficiary

• G9681

  This code is for onsite acute care treatment of a resident with copd or asthma; may only be billed once per day per beneficiary

• G9682

  This code is for the onsite acute care treatment a nursing facility resident with a skin infection; may only be billed once per day per beneficiary

• G9683

  Facility service(s) for the onsite acute care treatment of a nursing facility resident with fluid or electrolyte disorder. (may only be billed once per day per beneficiary). this service is for a demonstration project

• G9684

  This code is for the onsite acute care treatment of a nursing facility resident for a uti; may only be billed once per day per beneficiary

• G9685

  Physician service or other qualified health care professional for the evaluation and management of a beneficiary's acute change in condition in a nursing facility. this service is for a demonstration project

• G9686

  Onsite nursing facility conference, that is separate and distinct from an evaluation and management visit, including qualified practitioner and at least one member of the nursing facility interdisciplinary care team

---

HCPCS Level II codes and descriptors are approved and maintained jointly by the alpha-numeric editorial panel (consisting of CMS, the Health Insurance Association of America, and the Blue Cross and Blue Shield Association). — Updated 6/5/2026

CPT^® is a registered trademark of the American Medical Association (AMA). All rights reserved.